| 缩写名/全名 |
EXPERT REV GASTROENT
Expert Review of Gastroenterology & Hepatology |
||||||||||||||||||||
| ISSN号 | 1747-4124 | ||||||||||||||||||||
| 研究方向 | GASTROENTEROLOGY & HEPATOLOGY- | ||||||||||||||||||||
| 影响因子 | 2015:2.796, 2016:2.743, 2017:2.963, 2018:2.991, 2019:3.514, | ||||||||||||||||||||
| 出版国家 | ENGLAND | ||||||||||||||||||||
| 出版周期 | |||||||||||||||||||||
| 年文章数 | 108 | ||||||||||||||||||||
| 出版年份 | 0 | ||||||||||||||||||||
| 是否OA | No | ||||||||||||||||||||
| 审稿周期(仅供参考) | 较慢,6-12周 |
||||||||||||||||||||
| 录用比例 | 较易 | ||||||||||||||||||||
| 投稿链接 | https://mc.manuscriptcentral.com/erh | ||||||||||||||||||||
| 投稿官网 | http://www.tandfonline.com/toc/ierh20/current | ||||||||||||||||||||
| h-index | 41 | ||||||||||||||||||||
| CiteScore |
|
||||||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1747-4124%5BISSN%5D | ||||||||||||||||||||
| 中科院SCI期刊分区 （ 2018年新版本） |
|
||||||||||||||||||||
| 中科院SCI期刊分区 （ 2020年新版本） |
|
| 中国学者近期发表的论文 | |
| 1. | Urban-rural environmental exposure during childhood and subsequent risk of inflammatory bowel disease: a meta-analysis. Author: Song C1,2, Yang J3, Ye W1, Zhang Y4,5, Tang C1, Li X6, Zhou X1, Xie Y1,4,5. Journal: Expert Rev Gastroenterol Hepatol. 2019 Jun;13(6):591-602. doi: 10.1080/17474124.2018.1511425. Epub 2018 Aug 28. PubMed DOI |
| 2. | Effect of ω-3 polyunsaturated fatty acids on liver function and inflammatory reaction in patients undergoing hepatectomy: a systematic review and meta-analysis of randomized control trials. Author: Zhang C1,2, Lin J1, Li F1, Li Y1, Jiang B1, Bai H1, Zhang J1,2. Journal: Expert Rev Gastroenterol Hepatol. 2019 Apr;13(4):375-384. doi: 10.1080/17474124.2019.1578648. Epub 2019 Feb 22. PubMed DOI |
| 3. | Upper gastrointestinal hemorrhage in acute-on-chronic liver failure: prevalence, characteristics, and impact on prognosis. Author: Zhao H1, Zhao R1, Hu J1, Zhang X1, Ma J2, Shi Y3, Ma W1, Sheng J1, Li L1. Journal: Expert Rev Gastroenterol Hepatol. 2019 Mar;13(3):263-269. doi: 10.1080/17474124.2019.1567329. Epub 2019 Jan 18. PubMed DOI |
| 4. | Efficacy and safety of selective internal radiotherapy versus sorafenib for intermediate-locally advanced hepatocellular carcinoma: a systematic review and meta-analysis. Author: Zou J1, Zhu W1, Meng H1, Luo P1, Zhang J1. Journal: Expert Rev Gastroenterol Hepatol. 2019 Mar;13(3):271-279. doi: 10.1080/17474124.2019.1570135. Epub 2019 Jan 25. PubMed DOI |
| 5. | The association between nonalcoholic fatty liver disease and risk of colorectal adenoma and cancer incident and recurrence: a meta-analysis of observational studies. Author: Chen J1, Bian D2, Zang S3, Yang Z4, Tian G5, Luo Y5, Yang J5, Xu B6, Shi J7. Journal: Expert Rev Gastroenterol Hepatol. 2019 Apr;13(4):385-395. doi: 10.1080/17474124.2019.1580143. Epub 2019 Feb 19. PubMed DOI |
| 6. | Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in HIV infection: a metabolic approach of an infectious disease. Author: Coronel-Castillo CE1, Qi X2, Contreras-Carmona J1, Ramírez-Pérez OL1, Méndez-Sánchez N1. Journal: Expert Rev Gastroenterol Hepatol. 2019 Jun;13(6):531-540. doi: 10.1080/17474124.2019.1599284. Epub 2019 Apr 3. PubMed DOI |
| 7. | Proposal of a novel stage grouping of the Eighth Edition of American Joint Committee on Cancer TNM Staging System for Gastric Cancer: results from a retrospective study of 30 years clinical data from a single institute in China. Author: Zhang J1, Zou S1, Luo R1, Zhu Z1, Xu H1, Huang B1. Journal: Expert Rev Gastroenterol Hepatol. 2019 May 7:1-10. doi: 10.1080/17474124.2019.1613152. [Epub ahead of print] PubMed DOI |
| 8. | Prognostic factors in patients treated with transarterial radioembolization for unresectable and chemorefractory colorectal cancer with liver metastases. Author: Jia Z1, Paz-Fumagalli R2, Frey GT2, Sella DM2, McKinney JM2, Wang W2. Journal: Expert Rev Gastroenterol Hepatol. 2019 May 18. doi: 10.1080/17474124.2019.1621166. [Epub ahead of print] PubMed DOI |
| 9. | The role of lncRNAs in hepatocellular carcinoma: opportunities as novel targets for pharmacological intervention. Author: Zou H, Shao CX, Zhou QY, Zhu GQ, Shi KQ, Braddock M, Huang DS, Zheng MH. Journal: Expert Rev Gastroenterol Hepatol. 2016;10(3):331-40. doi: 10.1586/17474124.2016.1116382. Epub 2015 Nov 23. PubMed |
| 10. | Proposed therapies in primary biliary cholangitis. Author: Floreani A, Sun Y, Zou ZS, Li B, Cazzagon N, Bowlus CL, Gershwin ME. Journal: Expert Rev Gastroenterol Hepatol. 2016;10(3):371-82. doi: 10.1586/17474124.2016.1121810. Epub 2016 Jan 6. PubMed |
|
|
